The baseline patient characteristics of the two groups were similar in terms of menopausal status, histological type, tumor size, lymph node metastasis, histological grade, hormone receptor status, HER2 status, and adjuvant therapy (Table 1). This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.